FIELD: medicinal biotechnology, medicine, cardiology.
SUBSTANCE: invention relates to a soybean-base composition that comprises additionally phytoestrogenic compound and food cellular tissue. Composition can be used for preparing a pharmaceutical preparation and prophylaxis and/or treatment, and/or attenuation of multiple cardiovascular diseases. Composition is used in the dose providing reduction of serum blood cholesterol content, and/or serum blood LDLP-cholesterol content, and/or serum blood triglycerides content, and/or serum blood homocysteine content, and/or increase of the ratio HDLP-cholesterol to the content LDLP-cholesterol, and/or to the content of serum blood HDLP-cholesterol content, and/or reducing the deposition of cholesterol and/or triglycerides in artery walls, and/or prophylaxis, reducing or elimination of formation of lipid bands, and/or prophylaxis, reducing or elimination of formation of fibrous plaques, and/or reducing or elimination of formation of the complicated damage, and/or prophylaxis, reducing or elimination of risk in development of stenocardia, and/or prophylaxis, reducing or elimination risk in development of myocardium infarction. Invention promotes to normalization of lipid metabolism in humans.
EFFECT: improved method for prophylaxis and treatment.
58 cl, 5 dwg, 4 tbl, 2 ex
